SCHIAVON, ODDONE
 Distribuzione geografica
Continente #
NA - Nord America 5.851
AS - Asia 820
EU - Europa 741
SA - Sud America 23
OC - Oceania 4
AF - Africa 1
Totale 7.440
Nazione #
US - Stati Uniti d'America 5.844
CN - Cina 342
SG - Singapore 331
IT - Italia 154
FI - Finlandia 146
DE - Germania 132
UA - Ucraina 91
FR - Francia 69
VN - Vietnam 69
HK - Hong Kong 59
SE - Svezia 44
GB - Regno Unito 43
RU - Federazione Russa 34
BR - Brasile 18
IE - Irlanda 14
CA - Canada 7
IN - India 7
NL - Olanda 6
ES - Italia 5
TR - Turchia 4
AR - Argentina 2
AU - Australia 2
IL - Israele 2
NZ - Nuova Zelanda 2
AT - Austria 1
BE - Belgio 1
BO - Bolivia 1
CO - Colombia 1
ID - Indonesia 1
IR - Iran 1
JO - Giordania 1
KR - Corea 1
MA - Marocco 1
PH - Filippine 1
PY - Paraguay 1
RS - Serbia 1
TW - Taiwan 1
Totale 7.440
Città #
Fairfield 756
Woodbridge 651
Houston 491
Chandler 486
Ann Arbor 478
Jacksonville 461
Ashburn 306
Seattle 295
Wilmington 294
Santa Clara 242
Cambridge 232
Singapore 154
Princeton 133
Boardman 128
Beijing 96
San Diego 90
Nanjing 71
Dong Ket 69
Medford 66
Hong Kong 58
Roxbury 52
Helsinki 51
Padova 39
Des Moines 24
Nanchang 24
Verona 23
Norwalk 20
Hebei 18
Changsha 17
Dublin 14
Munich 14
Shenyang 13
Jiaxing 12
Guangzhou 10
Mestre 10
Venice 10
Cardiff 9
Redwood City 8
Tianjin 8
Shanghai 7
Kharkiv 6
London 6
Milan 6
Falls Church 5
Kilburn 5
Borås 4
Falkenstein 4
Ogden 4
Detroit 3
Dortmund 3
Indiana 3
Jinan 3
Leipzig 3
Ningbo 3
Rockville 3
Santi Cosma E Damiano 3
Yenibosna 3
Bengaluru 2
Bergamo 2
Buffalo 2
Florence 2
Gargnano 2
Groningen 2
Hangzhou 2
Lauterbourg 2
Los Angeles 2
Madrid 2
Ottawa 2
Tel Aviv 2
Valencia 2
Viadana 2
Zhengzhou 2
Acton 1
Adelaide 1
Amman 1
Amsterdam 1
Araraquara 1
Asunción 1
Atlanta 1
Auburn Hills 1
Aversa 1
Ballance 1
Bardolino 1
Bowling Green 1
Braço do Norte 1
Brussels 1
Cadeo 1
Cempaka-udik 1
Central 1
Chennai 1
Chuxiong 1
Cinisello Balsamo 1
Cláudio 1
Conegliano 1
Costa Mesa 1
Dearborn 1
Düsseldorf 1
Enschede 1
Erechim 1
Frankfurt Am Main 1
Totale 6.065
Nome #
Hyaluronic acid as a protein polymeric carrier: An overview and a report on human growth hormone 158
Drug and protein delivery by polymer conjugation 158
Chemical and Enzymatic Site Specific PEGylation of hGH: The Stability and in vivo Activity of PEG-N-Terminal-hGH and PEG-Gln141-hGH Conjugates 157
A Non-Covalent Antibody Complex for the Delivery of anti-cancer drugs 155
Polyethylene glycol-superoxide dismutase, a conjugate in search of exploitation 150
Accurate evaluation method of the polymer content in Monomethoxy(polyethylene glycol) modified proteins based on Amino acid analysis 129
Pegylated enzyme entrapped in poly(vinyl alcohol) hydrogel for biocatalytic application 128
A branched monomethoxypoly(ethylene glycol) for protein modification 126
Biopharmaceutical properties of uricase conjugated to neutral and amphiphilic polymers 125
Covalent immobilisation of transglutaminase: stability and applications in protein PEGylation 122
Physico-Chemical and Biological Properties of Monofunctional Hydroxy Teriminating Poly(N-Vinylpyrrolidone) Conjugated Superoxide Dismutase 118
Covalent modification of mushroom tyrosinase with different amphiphic polymers for pharmaceutical and biocatalysis applications 114
An improved procedure for the synthesis of branched polyethylene glycols (PEGs) with the reporter dipeptide Met-betaAla for protein conjugation. 114
Preservation of thrombolytic activity of urokinase modified with monomethoxypoly(ethylene glycol) 112
Preparation, physico-chemical and pharmacokinetic characterization of monomethoxypoly(ethylene glycol)-derivatized superoxide dismutase 112
Therapeutic proteins: a comparison of chemical and biological properties of uricase conjugated to linear or branched poly(ethylene glycol) and poly(N-acryloylmorpholine) 111
A Biodegradable Polymeric Carrier Based on PEG for Drug Delivery 110
Bassi polimeri dell'N-acriloil morfolina monofunzionalizzati ad un estremo per la preparazione di coniugati con enzimi, polipeptidi e farmaci 108
New synthetic polymers for enzyme and liposome modification 107
PEG-epirubicin conjugates with high drug loading 105
Polyethylene glycol (PEG)-dendron phospholipids as innovative constructs for the preparation of super stealth liposomes for anticancer therapy. 105
PEG-Ara-C conjugates for controlled release 104
Middle-term expansion of hematopoietic cord blood cells with new human stromal cell line feeder-layers and different cytokine cocktails 104
Modification of physico-chemical and biopharmaceutical properties of superoxide dismutase by conjugation to the co-polymer of divinyl ether and maleic anhydride 103
A Method to maintain the activity in polyethylene glycol-modified proteolytic enzymes 100
Improvement of pharmacokinetic, immunological and stability properties of asparaginase by conjugation to linear and branched monomethoxy poly(ethylene glycol) 99
Branched and linear poly(ethylene glycol): Influence of the polymer structure on enzymological, pharmacokinetic, and immunological properties of protein conjugates 93
PEG-doxorubicin conjugates: Influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity 93
Preparation and characterization of novel poly(ethylene glycol) paclitaxel derivatives 93
PHEA-Graft-Polymethacrylate Supramolecular Aggregates for Protein Oral Delivery 93
Synthesis and molecular weight characterization of low molecular weight end-functionalized poly(4-acryloylmorpholine) 90
Protective effect of superoxide dismutase and polyethylene glycol-linked superoxide dismutase against renal warm ischemia/reperfusion injury 86
End functionalized PVP as new oligomer for enzyme modification 85
Peg-doxorubicin conjugates with high loading 84
Photoinactivation of enzymes by linear and angular furocoumarins. 83
Polysialic acid as a drug carrier: evaluation of a new polysialic acid–epirubicin conjugate and its comparison against established drug carriers 83
Antitumoral activity of peg-gemcitabine prodrugs targeted by folic acid 82
Molecular bases of biological properties of angiogenin: application in tissue engineering. 81
Extensive crosslinking between subunits of oligomeric proteins induced by furocoumarins plus UV-A irradiation. 81
Relevance of folic acid/polymer ratio in targeted PEG-epirubicin conjugates 80
Biologically active conjugates having a detector reporter moiety and method of identificationof said derivative 77
Drug-Protein Interaction: 8-Methoxy Psoralen as Photosensitizer of Enzymes and Amino Acids 76
Enzymatically active subunits of Bacillus stearothermophilus enolase bound to Sepharose. 76
Controlled Drug Delivery Microspheres for Osteogenic Differentiation 75
Molecular bases of angiogenin: Applications in tissue engineering 74
Influence of PEGylation on the release of low and high molecular-weight proteins from PVA matrices 74
New active poly(ethylene glycol) derivative for amino coupling 74
Enzyme modification by MPEG with an amino acid or peptide as spacer arms 74
Poly(N-acryloylmorpholine) can be used in alternative to poly(ethylene glycol) for protein modification. 73
New chain terminated N-vinyl lactam polymer and grafts copolymers and methods for making same 73
Anti-inflammatory and pharmacokinetic properties of superoxide dismutase derivatized with polyethylene glycol via active esters. 72
The modification of ribonuclease-A by near ultraviolet irradiation in the presence of psoralen. 72
Surface modification of proteins. Activation of monomethoxy-polyethylene glycols by phenylchloroformates and modification of ribonuclease and superoxide dismutase. 71
Active poly(ethylene glycol) carbamate for protein modification 70
A new method for high selective TGase-mediated PEGylation of salmon calcitonin and human growth hormone 70
New active poly(ethylene glycol) derivative for amino coupling 67
pH-responsive liposomes for enhanced drug delivery to the tumour. 66
Poly(N-acryloylmorpholine) as a new soluble support for the liquid-phase synthesis of oligonucleotides. 65
New PEG's for peptides and protein modification, suitable for the identification of the peghilation site 64
Distribution of catalase, ribonuclease and superoxide dismutase modified by monomethoxy (polyethylene glycol) into rat central lymph and lymphatic nodes 63
Polymers of N-acryloylmorpholine activated at one end and conjugated with bioactive materials and surfaces 60
Bassi polimeri dell' N-vinilpirrolidone monofunzionalizzati ad un estremo per la preparazione di coniugati con enzimi, polipeptidi, farmaci 60
The effect of psoralens and angelicins on proteins in the presence of UV-A irradiation. 60
Tumor targeting of doxorubicin bound to peg of different size and shape. 27th International Symposium on controlled release of bioactive materials. 58
Dendritic PEG-epirubicin conjugates with high loading 58
Multibranched PEG to improve the conjugate loading of Ara-C 58
Synthesis and Biological Properties of Folate-PEG-Gemcitabine 56
Controlled drug delivery microspheres for osteogenic differentiation 56
Solution-phase site-specific preparation of GRF-PEG conjugates 56
PEG superoxide dismutase derivatives: anti-inflammatory activity in carrageenan pelurisy in rats. 55
Molecular relationship of different activities of angiogenin: application in tissue engineering. 53
Synthesis and Pharmacokinetic studies of dendritic PEG-epirubicin 51
hGH-PEG-betaAla coniugate releasing the native protein: pharmacokinetic evaluation in monkeys and activity investigation in hypophysectomized rats. 51
Folate-targeted PEG-Gemcitabine 51
Poly(N-Acryloylmorpholine) can be used in alternative to poly(ethylene glycol) for protein modification 50
A high molecular weight form of human urinary urokinase. 48
Metodo per mantenere l'attività di enzimi proteolitici modificati con polietilenglicole 47
Synthesis and biological studies of PEG-epirubicin conjugates 47
Relevance of folic acid/polymer ratio in targeted epirubicin polymer conjugates. 47
Multi-armed monofunctional and hydrolitically stable derivatives of poly (ethylene glycol) and related polymers for modification of surfaces and molecules 46
Polymeric prodrug of gemcitabine 45
Studies on natural and synthetic high molecular weight forms of urokinase 45
Polyethylene glycol (PEG)-dendron phospholipids as innovative pharmaceutical products to make super stealth liposomes for anticancer therapy 45
Folic acid targeted PEG-epirubicin: the influence of folic acid/PEG ratio on coniugate cytotoxicity. 42
The study of the furocoumarin-serum albumin complex by difference spectrophotometry and gel exclusion. 41
Epirubicine-PEG-folate conjugates: the effects of folic acid and folic acid / polymer ratio on conjugates cytotoxicity and cellular uptake. 40
polymeric conjugate of phospholipids 39
Poly(ethylene glycol)-Poly(ester-carbonate) Blok Copolymers Carrying PEG-Peptidyl-Doxorubicin Pendant Side Chain: Synthesis and Evaluation as Anticancer Conjugates 39
Drug protein interaction: inhibition of glutamate dehydrogenase by psycoactive butyrophenones. 39
General stability of thermophilic enzymes: studies on 6-phosphogluconate dehydrogenase from Bacillus stearothermophilus and yeast. 39
The binding of 8-methoxypsoralen by human serum albumin. 39
Evaluation of monomethoxypolyethyleneglycol derivatized superoxide dismutase in blood and evidence for its binding to blood cells. 39
Folic acid targeted PEG-epirubicin conjugate with lysosomotropic drug release 38
Drug-protein interaction: plasma protein binding of furocoumarins. 37
Dendritic PEG liposomes for the delivery of anticancer drugs 34
Drug protein interaction: displacement of albumin bound 8-methoxypsoralen by drugs. 32
Totale 7.468
Categoria #
all - tutte 27.001
article - articoli 19.911
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 2.184
selected - selezionate 0
volume - volumi 455
Totale 49.551


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020321 0 0 0 0 0 0 0 0 0 154 88 79
2020/20211.007 33 84 10 74 38 119 52 115 158 89 126 109
2021/20221.000 7 167 136 64 39 28 46 110 49 9 126 219
2022/2023942 210 95 7 82 166 129 2 70 106 3 57 15
2023/2024324 16 71 39 28 14 5 24 8 15 18 47 39
2024/20251.000 0 73 94 57 408 44 55 133 111 25 0 0
Totale 7.468